Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Fresenius Medical Care AG & Co. KGaA    FME   DE0005785802

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/11/2019 | 03:50am EST

DGAP Post-admission Duties announcement: Fresenius Medical Care AG & Co. KGaA / Fresenius Medical Care AG & Co. KGaA / Announcement pursuant to Art. 5 para. 1 lit. b), para. 3 of Regulation (EU) No 596/2014 and Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052
Fresenius Medical Care AG & Co. KGaA: Release of a capital market information

11.11.2019 / 09:44
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


- Share buy-back - 21st Interim Report

In the period from November 4, 2019 until and including November 8, 2019, a total of 177,000 shares were repurchased within the framework of the share buy-back programme of Fresenius Medical Care AG & Co. KGaA ('Fresenius Medical Care') announced on June 14, 2019 pursuant to Art. 5 para. 1 lit. a) of Regulation (EU) No 596/2014 and Art. 2 para. 1 of Delegated Regulation (EU) 2016/1052.

The purchase was carried out exclusively by a credit institution commissioned by Fresenius Medical Care via the XETRA trading platform on the Frankfurt Stock Exchange:

Day of repurchase Aggregated volume in number of shares Weighted average share price
in EUR
04.11.2019 36,000 66.5550
05.11.2019 36,000 67.7284
06.11.2019 35,000 67.7370
07.11.2019 35,000 68.6833
08.11.2019 35,000 68.6178
 

The total volume of shares repurchased within the framework of this share buy-back in the period from June 17, 2019 until and including November 8, 2019 therefore amounts to 3,903,735 shares.

Detailed information on the transactions pursuant to Art. 2 para. 3 of Delegated Regulation (EU) 2016/1052 is available on Fresenius Medical Care's website at www.freseniusmedicalcare.com under section Investors.

Fresenius Medical Care AG & Co. KGaA
represented by Fresenius Medical Care Management AG
represented by its Management Board

Bad Homburg v.d.H., November 11, 2019



11.11.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Germany
Internet: www.freseniusmedicalcare.com

 
End of News DGAP News Service

909271  11.11.2019 

fncls.ssp?fn=show_t_gif&application_id=909271&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FRESENIUS MEDICAL CARE AG
12/09FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
12/02FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/29FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 41 of the Wp..
EQ
11/25FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/18FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/11FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/04FRESENIUS MEDICAL CARE AG & CO. KGAA : Release of a capital market information
EQ
11/04FRESENIUS : Buys Colombia's CediMed in EUR40 Million Investment
DJ
11/01FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 50 of the Wp..
EQ
10/31FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 40, Section ..
EQ
More news
Financials (USD)
Sales 2019 19 366 M
EBIT 2019 2 553 M
Net income 2019 1 311 M
Debt 2019 12 365 M
Yield 2019 1,76%
P/E ratio 2019 16,8x
P/E ratio 2020 14,2x
EV / Sales2019 1,75x
EV / Sales2020 1,62x
Capitalization 21 564 M
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 85,89  $
Last Close Price 73,21  $
Spread / Highest target 51,8%
Spread / Average Target 17,3%
Spread / Lowest Target -33,4%
EPS Revisions
Managers
NameTitle
Rice Powell Chairman-Management Board
Dieter Schenk Chairman-Supervisory Board
Helen Giza Chief Financial Officer
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer